DOI: 10.4244/EIJV11I12A258

The Mitral Valve Meeting in Zurich – a world upside down

Patrick W. Serruys, Editor-in-Chief

I recently had the pleasure of participating once again in the Mitral Valve Meeting in Zurich under the course directorship of Francesco Maisano and Marty Leon. This year’s edition, the second, featured even more interaction and practical workshops whilst maintaining the strong contemporary Heart Team philosophy. What is fascinating about this meeting is the high, uppermost level of education for both the surgeon and the interventionalist. It is my assessment that the audience was split 50-50 between the two groups, which in itself is a remarkable achievement, and that furthermore the Heart Team approach clearly indicates that the two communities are now working side by side.

The first day consisted of four module sessions comprising eight different workshops for each module. All those who registered for the meeting had to participate in the workshops. As an example, let me describe one workshop in which I participated as faculty member. Our workshop team included Mark Reisman from Seattle, who is also well known as a fabulous teacher of anatomy (in particular, the anatomical relationships with devices), Alberto Weber a surgeon from the Zurich team, an echographist from Zurich and myself. Eight to ten tables were set up in the workshop room and on each table there was a pig’s heart. In fact, in all, 150 pigs’ hearts were dissected by the physicians attending the workshops. One may remark in jest that these animals not only feed our stomachs but also feed our brains with a new understanding of mitral interventions.

The instructor started to dissect the heart under angioscopy, with the images being projected on a large 3D screen. Each attendee had special 3D spectacles aiding a better perception of the projected images on the screen with which we systematically learned about the trigone of the mitral valve, the primary and secondary chordae, the basal chordae, and the insertion to the papillary muscle. For the whole workshop we had to dissect the heart in great detail. In between, there were short lectures on 3D echography, the anatomy and implantation of surgical devices, something which was also demonstrated live during the workshop.

I felt that all the attendees during this meeting may have reached the ultimate level of education. The other two days were spectacular in the sense that more than ever we realised the extraordinary privilege of the surgeon operating on a static heart, with a perfect view of the anatomy in terms of prolapse within the P2 segment. This is knowledge which the average interventionalist has never been exposed to in his career. Beyond this extraordinary asset of the surgeon, I realised that they, the surgeons, were working on a non-beating heart with a perfect view but were unable to judge by haemodynamics and motion what they had achieved by their surgery. Their most sophisticated assessment is the water test which consists of injecting a certain amount of water into the left ventricle to see if there is a leak or reflux of water into the left atrium. Following this wonderful case, Alberto Weber implanted two or three artificial chordae. This was then followed by Francesco Maisano’s case, which had the totally opposite perception of a somewhat similar pathology.

During Francesco’s case, it was the surgeon performing the percutaneous intervention – to coin a phrase, the world upside down. Amazingly, he implanted three clips on the mitral valve, while at the same time we could see the V-wave reduce within 45 minutes from 40 mmHg to 12 mmHg. This is in effect basically normalising the pressure in the left atrium and monitored, by the way, via a pigtail which ran parallel to the sheath for the clips. It is at this moment that one realises that the imaging is not a direct view but indirect, using 2D and 3D echo, and yet seeing with the beating heart the whole haemodynamic change during the treatment. This improvement was progressively achieved with the implantation of each clip serially implanted (in total three), with continuous assessment of the haemodynamics using 2D and 3D echo but also Doppler for flow and velocity assessment. The contrast is that, while the surgeon is a tailor working on something “static”, the interventionalist is working “dynamically” such that the effect of his work can be judged immediately. And as a little footnote, after the 3 clip implantations, Francesco took advantage of having access to the left atrium to close the left appendage...as a good surgeon would do...one stone two birds.

Personally, I think that the perception of the future has never been so evident. I would not like to be tempted into making a prediction but, with 26 to 40 devices existing in the mitral space, devices which basically mimic the ingenious, dexterous and masterful surgeon over the last 30 to 40 years, this percutaneous approach is probably the way forward.

Moving on from the Zurich meeting, I am now eagerly looking forward to PCR Innovators Day in Paris in May where one of the four key topics during this meeting will be the latest innovations in the mitral and tricuspid valve interventional arena under the expert guidance of Nicolo Piazza and Michel Darnaud. And then, of course, the highlight of the year will be the world’s largest educational meeting on valvular heart disease and percutaneous valve interventions – PCR London Valves in September in London.

Volume 11 Number 12
Mar 18, 2016
Volume 11 Number 12
View full issue


Key metrics

On the same subject

10.4244/EIJV12I2A25 Jun 10, 2016
PCR Innovators Day: dreaming with our eyes wide open…
Wijns W et al
free

10.4244/EIJV11SWA8 Sep 17, 2015
Mitral valve anatomy: pre-procedural screening and imaging techniques
González-Gómez A et al
free

10.4244/EIJV11SWA10 Sep 17, 2015
Transcatheter mitral valve repair: a brief review
Barbanti M et al
free

EXPERT REVIEW

10.4244/EIJ-D-17-00571 Sep 24, 2017
The big parade: emerging percutaneous mitral and tricuspid valve devices
Natarajan D et al
free

10.4244/EIJV13I10A178 Nov 20, 2017
PCR London Valves Innovators Day 2017. Where will valve intervention be in 2025?
Dawkins S et al
free

10.4244/EIJV12SYA1 Sep 18, 2016
Welcome to PCR London Valves 2016: back to the UK
Tamburino C et al
free

10.4244/EIJV13I3A37 Jun 20, 2017
An old dichotomy in the space(r) age
Khamis R and Mylotte D
free
Trending articles
337.88

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
283.98

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
226.03

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
209.5

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.4

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
150.28

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
103.48

Expert consensus

10.4244/EIJ-E-22-00018 Dec 4, 2023
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved